Back to Search
Start Over
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
- Source :
-
Journal of the National Cancer Institute [J Natl Cancer Inst] 2012 Aug 22; Vol. 104 (16), pp. 1264; author reply 1266-8. Date of Electronic Publication: 2012 Jul 31. - Publication Year :
- 2012
- Subjects :
- Female
Humans
Antineoplastic Agents, Hormonal therapeutic use
Breast Neoplasms drug therapy
Breast Neoplasms enzymology
Breast Neoplasms epidemiology
Breast Neoplasms prevention & control
Cytochrome P-450 CYP2D6 genetics
Glucuronosyltransferase genetics
Neoplasm Recurrence, Local epidemiology
Neoplasm Recurrence, Local prevention & control
Nitriles therapeutic use
Polymorphism, Single Nucleotide
Postmenopause
Tamoxifen therapeutic use
Triazoles therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1460-2105
- Volume :
- 104
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- Journal of the National Cancer Institute
- Publication Type :
- Report
- Accession number :
- 22851270
- Full Text :
- https://doi.org/10.1093/jnci/djs304